Daily Anesthesiology Research Analysis
Three anesthesia-relevant studies stand out today: a randomized trial shows prolonged Valsalva maneuvers during HIFU under general anesthesia markedly increase EEG burst suppression and emergence agitation, supporting a ≤5.2-minute limit per episode. A randomized trial of tubeless anesthesia (LMA plus regional blocks) for thoracoscopic wedge resection accelerates recovery and reduces airway symptoms versus double-lumen intubation. A very large UK Biobank cohort identifies multifactorial preopera
Summary
Three anesthesia-relevant studies stand out today: a randomized trial shows prolonged Valsalva maneuvers during HIFU under general anesthesia markedly increase EEG burst suppression and emergence agitation, supporting a ≤5.2-minute limit per episode. A randomized trial of tubeless anesthesia (LMA plus regional blocks) for thoracoscopic wedge resection accelerates recovery and reduces airway symptoms versus double-lumen intubation. A very large UK Biobank cohort identifies multifactorial preoperative risk factors for chronic post-surgical pain, informing prevention and resource allocation.
Research Themes
- Tubeless anesthesia and airway strategies in thoracic surgery
- Perioperative neurophysiology: Valsalva maneuver effects on EEG and recovery
- Chronic post-surgical pain risk stratification using population-scale data
Selected Articles
1. Impact of valsalva maneuver duration on brain function in patients undergoing high-intensity focused ultrasound liver ablation: a randomized controlled trial.
In a three-arm RCT of 153 patients undergoing HIFU under general anesthesia, Valsalva episodes >5.2 minutes markedly increased EEG burst suppression (66.7%) versus short VM (30.8%) or control (2.0%). Long VM also increased emergence agitation and worsened QoR-15, while delirium differences were not statistically significant. Findings support limiting VM duration per episode to ≤5.2 minutes to mitigate neurophysiologic stress.
Impact: This RCT provides mechanistic EEG evidence linking prolonged Valsalva to brain suppression and poorer recovery metrics, delivering an actionable intraoperative time threshold. It directly informs anesthetic management during procedures that employ Valsalva.
Clinical Implications: Limit Valsalva episodes to ≤5.2 minutes when feasible; anticipate agitation after prolonged VM and consider EEG-guided titration to avoid burst suppression. Coordinate with proceduralists to segment VM requests and allow recovery periods.
Key Findings
- Burst suppression rates increased from 2.0% (control) to 30.8% (≤5.2 min VM) and 66.7% (>5.2 min VM); p<0.001.
- Long VM reduced alpha/beta power and increased permutation entropy versus control, indicating cortical depression.
- Emergence agitation was highest with long VM (64.7%) and QoR-15 scores were lowest; delirium differences were not significant.
Methodological Strengths
- Randomized, three-arm design with intent-to-treat analysis
- Objective EEG metrics (power spectral density, entropy) and clinically relevant recovery endpoints
Limitations
- Single procedural context (HIFU for liver cancer) may limit generalizability
- Delirium differences were underpowered (low event rates); EEG used 4-channel monitoring
Future Directions: Validate VM time thresholds across surgeries; integrate continuous EEG-guided protocols; study hemodynamic-cerebral coupling during VM to refine safe practice windows.
BACKGROUND: Intermittent Valsalva maneuver (VM) is commonly used to facilitate high-intensity focused ultrasound (HIFU) ablation. However, the optimal duration of a VM in terms of adverse impacts on brain function is unknown. This prospective study explored the impact of different VM durations on brain function in patients undergoing HIFU ablation surgery for hepatic cancer. METHODS: Adult patients scheduled for HIFU ablation for liver cancer under general anaesthesia were randomized into control group, ≤ 5.2 minutes per VM episode (short VM group), or > 5.2 minutes per VM episode (long VM group). Four-channel electroencephalogram was conducted using SedLine® to record brain electrical parameters (e.g., power spectral density, entropy values, and cross-frequency domain coupling). The primary endpoint was burst suppression in the intent-to-treat population that included all enrolled subjects. Key secondary endpoints included postoperative delirium, emergence agitation, and postoperative recovery quality. RESULTS: A total of 156 subjects were screened, and 153 were randomized: 50, 52, and 51 subjects in the control, short VM, and long VM groups, respectively. The rate of burst suppression was 2.0% (1/50), 30.8% (16/52), and 66.7% (34/51) in the control, short VM, and long VM groups, respectively (p < 0.001). The long VM group also had lower alpha and beta band power spectral density, and higher permutation entropy compared to the control group. The rate of postoperative delirium was 0.0% (0/48), 0.0% (0/49) and 6.1% (3/49) in the control, short VM, and long VM groups, respectively (p = 0.107). The long VM group had the highest rate of emergence agitation (64.7% vs 2.0% in the control group and 28.8% in the short VM group, p < 0.001), and the lowest Quality of recovery-15 (QoR-15) scores [106 (100-109) vs 110 (107-118) in the control group and 110 (102-114) in the short VM group, p < 0.001]. CONCLUSIONS: A VM lasting for > 5.2 minutes per episode resulted in substantial increases in the rates of burst suppression in adult patients undergoing HIFU ablation for liver cancer. Based on these findings, it is recommended that the VM should be limited to ≤ 5.2 minutes per episode if possible.
2. Application of tubeless anesthesia for enhanced recovery after thoracoscopic wedge resection of the lung: a randomized trial.
In 90 patients randomized to double-lumen intubation versus tubeless anesthesia (LMA plus intercostal or paravertebral block), tubeless strategies shortened time to feeding and ambulation, decreased length of stay and costs, and reduced cough, sore throat, and hoarseness. Hemodynamics were more favorable at key time points, with overall shorter intubation/extubation/recovery times. Tubeless anesthesia appears safe and effective for selected short thoracoscopic wedge resections.
Impact: This randomized comparison provides direct evidence supporting a tubeless approach as an ERAS-enabling strategy in thoracic anesthesia, with tangible improvements in recovery and airway morbidity.
Clinical Implications: For short, low-risk thoracoscopic wedge resections, consider LMA plus regional blocks to avoid double-lumen intubation, reduce airway complications, and accelerate discharge. Careful patient selection and CO2 monitoring are essential.
Key Findings
- Tubeless groups (LMA + intercostal or paravertebral block) had shorter time to feeding and ambulation and reduced hospital stay and costs compared with double-lumen intubation.
- Lower incidence of postoperative cough, sore throat, and hoarseness with tubeless approaches.
- Shorter intubation, extubation, and overall recovery times; lower MAP/HR at certain time points.
Methodological Strengths
- Prospective randomized three-arm design comparing two tubeless techniques versus standard care
- Comprehensive perioperative endpoints including recovery metrics, airway symptoms, hemodynamics, and costs
Limitations
- Single-center study with modest sample size; limited to short-duration wedge resections
- End-tidal CO2 details truncated in abstract; CO2 retention risks require careful monitoring
Future Directions: Multicenter trials assessing broader thoracic procedures, long-term pulmonary outcomes, and standardized selection criteria; optimization of block techniques and ventilation strategies.
BACKGROUND: The concept of tubeless anesthesia has emerged as a transformative approach in modern anesthesiology, particularly within the framework of enhanced recovery after surgery (ERAS). However, research regarding the application of tubeless anesthesia in the context of thoracoscopic wedge resection remains limited, particularly with respect to comparative studies of different anesthesia techniques, such as the use of a laryngeal mask airway (LMA) combined with various nerve block approaches. This prospective study evaluated the feasibility and safety of tubeless anesthesia in thoracoscopic wedge resection and its impact on rapid postoperative recovery, providing more evidence for clinical practice. METHODS: Ninety patients scheduled for thoracoscopic wedge resection were randomized into three groups, with 30 patients in each group: double-lumen endotracheal intubation (Group A), LMA + intercostal nerve block (Group B), and LMA + paravertebral nerve block (Group C). Satisfaction with the surgical field, operation time, hospitalization duration, anesthesia costs, hospitalization costs, postoperative feeding time, and ambulation time were recorded. Intraoperative and postoperative adverse events, perioperative anesthesia-related parameters, hemodynamic variables at five time points [pre-intubation (T0), 3 min post-intubation (T1), at surgery initiation (T2), at surgery completion (T3), and post-extubation (T4)], and arterial blood gas (ABG) indices at four time points [pre-intubation (T0'), 3 min post-intubation (T1'), 45 min post-intubation (T2'), and 1 hour post-surgery (T3')] were analyzed. RESULTS: Compared with Group A, Groups B and C presented significantly shorter postoperative feeding times, earlier ambulation, shorter hospitalization durations, and lower anesthesia/hospitalization costs (P<0.05). The incidence of postoperative cough, sore throat, and hoarseness was lower in Groups B and C than in Group A (P<0.05). Compared with those in Group A, the total intubation time, extubation time, and recovery time in Groups B and C were significantly shorter (P<0.05). At T1 and T4, the mean arterial pressure (MAP) and heart rate (HR) were lower in Groups B and C than in Group A (P<0.05). At T2 and T3, the end-tidal CO CONCLUSIONS: Tubeless anesthesia with preserved spontaneous breathing is safe and effective in selected low-risk patients undergoing short-duration thoracoscopic wedge resection, reducing postoperative complications and promoting enhanced recovery. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2300073484.
3. The preoperative risk factors of chronic post-surgical pain: a retrospective cohort study in the UK Biobank.
In 125,939 UK Biobank participants, 3,609 developed chronic post-surgical pain. Twenty-one preoperative factors were associated with higher CPSP risk, with 15 showing strong associations (P<0.001), including age, obesity, socioeconomic status, sleep insufficiency, smoking, prior surgical burden, polygenic risk, and biomarkers (e.g., cystatin C, GGT, RDW, monocytes). Findings support multifactorial risk stratification and targeted prevention.
Impact: This is one of the largest perioperative pain epidemiology studies to date, integrating socioeconomic, behavioral, genetic, and laboratory markers to illuminate CPSP risk determinants.
Clinical Implications: Incorporate CPSP risk screening into preoperative assessment, targeting modifiable risks (smoking cessation, sleep optimization, sodium reduction), and tailoring analgesic strategies for high-risk patients informed by biomarker and socioeconomic profiles.
Key Findings
- Among 125,939 participants, 3,609 CPSP cases occurred; 21 preoperative risk factors were significant overall.
- Fifteen factors had strong associations (P<0.001), including older age, obesity, lower education/income, prior surgeries, polygenic risk score, insufficient sleep, smoking, and biomarkers (cystatin C, GGT).
- Additional signals included high-sodium diet, hypertension, increased MCHC, RDW, and monocyte count (P<0.05); sensitivity analyses addressed reverse causality and timing.
Methodological Strengths
- Very large cohort with broad factor domains and Cox modeling
- Interaction and sensitivity analyses to mitigate reverse causality and timing biases
Limitations
- Retrospective design with potential residual confounding and measurement bias
- CPSP ascertainment via questionnaire at a single time window (2019) may introduce misclassification
Future Directions: Prospective validation in diverse populations; develop and test CPSP risk calculators; interventional trials targeting modifiable risk domains (sleep, smoking, diet) and biomarker-guided strategies.
BACKGROUND: Lacking preoperative CPSP risk factors that cover all surgical modalities, are based on large-scale databases, and are free from patients' subjective elements and compliance. MATERIALS AND METHODS: This study utilised the UK Biobank, whose baseline assessment was conducted between 2006 and 2010. It centred on participants who responded to the CPSP questionnaire during January to February 2019. In conjunction with previous reviews, 67 potential risk factors were identified and categorised into 10 domains. The Cox proportional hazards regression model was employed to analyse the relationships between these factors and CPSP. Finally, interaction and sensitivity analyses were performed to mitigate biases arising from potential reverse causalities among the risk factors, as well as the matching of the operation time with the CPSP occurrence time and data imputation. RESULTS: Of 125,939 included participants with 74,046 (58.8%) women and 56.8 years mean age at baseline, 3609 incident CPSP cases were observed. After stepwise Cox regression, 21 factors were significantly associated with a higher CPSP risk. Among them, 15 factors demonstrated a significant association with increased CPSP risk (P < 0.001). These factors include older age, obesity, lower educational attainment, lower income, a higher surgery times before baseline, elevated PRS, insufficient sleep, smoking, longer time spent outdoors in summer or winter, maternal smoking around birth, chronic condition or disability, regular analgesic use, elevated cystatin C and gamma glutamyl transferase. Additionally, high-sodium diets, higher mismatched count, hypertension, and related hematological indicators such as increased mean corpuscular hemoglobin concentration, red cell distribution width, and monocyte count were also found to significantly elevate the risk of CPSP (P < 0.05). CONCLUSIONS: Our findings contribute to a more comprehensive understanding of CPSP risk factors and pathogenesis, which hold significant implications for developing targeted preventive strategies, optimizing perioperative pain management, and improving the allocation of healthcare resources.